News | Artificial Intelligence | September 07, 2023

Vektor Medical Announces Enhanced AI-based vMap for Improved Cardiac Ablation Outcomes, Non-Invasive Mapping of Cardiac Arrhythmias

Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap. The newly updated vMap software integrates additional automation and advanced visualization features, and is designed to improve ablation outcomes and procedural efficiencies, according to a statement issued by the San Diego, CA-based company.

Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap, which were designed to improve ablation outcomes and procedural efficiencies.

Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap. The newly updated vMap software integrates additional automation and advanced visualization features, and is designed to improve ablation outcomes and procedural efficiencies. Image courtesy: Vektor Medical


September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ECG data, has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap. Designed to improve ablation outcomes and procedural efficiencies, the newly updated vMap software integrates additional automation and advanced visualization features.

vMap is the only FDA-cleared, AI-based non-invasive solution that unlocks the data contained in a standard 12-lead ECG, enabling physicians to rapidly and accurately locate arrhythmia source locations. According to a statement issued by the San Diego, CA-based company, the software upgrades are designed to improve the accuracy, visualization, and efficiency of arrhythmia analysis and interpretation.

The updates include:

- Beat Assist: Software recommends and auto-selects arrhythmic beats of interest that may indicate the source location of an arrhythmia. This new functionality reduces uncertainty and increases confidence when identifying arrhythmic beats, speeding up procedure planning process.

- Upgraded Heart Model: vMap’s new model provides a highly realistic and more detailed representation of the heart. It improves visualization and understanding of spatial distribution of the target lesion sites, increasing analysis accuracy and translation.

- Automated ECG Baseline Correction: The revolutionary signal conditioning removes baseline noise from input ECG signals, improving accuracy and ultimately providing higher-quality ECG signals for analysis.

“The vMap software upgrades and enhanced visualization capabilities have made a significant impact on my ability to see the arrhythmia source location and plan the EP procedure,” stated Gregory Kent Feld, MD, Director of Electrophysiology at University of San Diego Health. “The level of detail and clarity solidify vMap as a cutting-edge solution in arrhythmia care and will empower EPs to navigate the heart with more accuracy and confidence."

In addition, the upgrades include a series of workflow enhancements to simplify analysis, aid with pattern recognition and abnormality identification and reduce mapping time. These updates, noted the company announcement, highlight Vektor Medical’s commitment to continuous innovation to transform arrhythmia care.

vMap localizes arrhythmia sources for focal and fibrillation-type arrhythmias, including atrial fibrillation, unlocking actionable insights contained in a standard 12-lead ECG, and enabling physicians to rapidly and accurately locate arrhythmia source locations. According to the company, through this AI-based, non-invasive arrhythmia analysis technology, Vektor Medical aims to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.

More information: www.vektormedical.com


Related Content

News | Cardiovascular Business

May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Home May 14, 2024
Home
News | Cardiovascular Business

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

Home May 03, 2024
Home
News | Cardiovascular Business

April 29, 2024 — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure ...

Home April 29, 2024
Home
News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
Subscribe Now